Pliant Therapeutics, Inc. ( PLRX) - Stock Earnings
PLRX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 6, 2026, midnight | — / — | — | — / — | — |
PLRX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -26.3 million USD | — USD |
| 2025Q4 | -23.6 million USD | — USD |
| 2026Q1 | -20.0 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
PLRX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -161.3 million USD | 1.6 million USD |
| 2024 | -210.3 million USD | — USD |
| 2025 | -149.3 million USD | — USD |
| 2026 Est. | — | — |
PLRX
Price: $1.09
52 week price:
Earnings Per Share: -1.83 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.0 million
Market Capitalization: 72.4 million